Medicines for Malaria Venture (MMV) is a leading product development partnership whose mission is to reduce the burden of malaria in disease-endemic countries by discovering, developing, and delivering effective and affordable antimalarial drugs. Established in 1999, MMV has earned global recognition for its role in bringing new, life-saving treatments to vulnerable populations, particularly children and pregnant women, through innovative public-private collaborations.

With a dynamic and mission-driven work culture, MMV attracts diverse talent committed to global health equity, offering flexible work arrangements and opportunities for impactful careers in scientific research, public health, and project management. Over the years, MMV has evolved into a global force in antimalarial R&D, with a robust pipeline of new molecules and therapies made possible through its collaborative model involving academia, industry, and public health institutions.

Operating from its headquarters in Geneva, Switzerland, MMV has a global reach with projects in over 50 countries, supported by a values-driven ethos emphasizing scientific excellence, transparency, equity, and access. Deeply committed to corporate social responsibility, MMV invests in capacity building, community engagement, and health systems strengthening in malaria-endemic regions. More information about its groundbreaking work can be found at https://www.mmv.org.